Global Antipyretic Analgesics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis. The global Antipyretic Analgesics market size was valued at US$ 2899 million in 2023 and is forecast to a readjusted size of USD 3143 million by 2030 with a CAGR of 1.2% during review period. From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application. Antipyretic analgesic of the world"s main producers have Mallinckrodt Pharmaceuticals, IOL, ruan...Read more | USD 3,480.00 |
Global Vitamin Fudge Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Vitamin fudge is a vitamin supplement in the form of fudge. Compared with traditional tablets and capsules, the chewiness and flavor (oranges, cherries, raspberries, etc.) make them attractive to both children and adults, and chewing gum candy is easier than swallowing tablets. The global Vitamin Fudge market size was valued at US$ 1887 million in 2023 and is forecast to a readjusted size of USD 2542 million by 2030 with a CAGR of 4.4% during review period. The industry"s leading producers are Bayer, Church & Dwight Co and Pharmavite, which accounted for 14.79%, 11.07% and 5.14% of revenue in 2019, respectively. This report is a detailed and comprehensive analysis for global Vitamin Fudge market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that...Read more | USD 3,480.00 |
Global Hematopoietic Stem Cells Transplantation Market 2024 by Company, Regions, Type and Application, Forecast to 2030Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. The global Hematopoietic Stem Cells Transplantation market size was valued at US$ 2641 million in 2023 and is forecast to a readjusted size of USD 3843 million by 2030 with a CAGR of 5.6% during review period. Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they...Read more | USD 3,480.00 |
Global Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues. The global Cell Therapy market size was valued at US$ 120550 million in 2023 and is forecast to a readjusted size of USD 284210 million by 2030 with a CAGR of 13.2% during review period. The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%. Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%. North Americas is the largest consumption place, with a consumption market...Read more | USD 3,480.00 |
Global Hemostatic Gel Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China"s hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest...Read more | USD 3,480.00 |